Mytos develops advanced automation systems for mammalian cell culture, transforming a critical yet labor-intensive process in biotechnology. By creating highly efficient machines that automate human cell production, Mytos aims to accelerate drug discovery and development, particularly in the realm of cancer therapies. The company's mission is to streamline operations in biopharma, enabling researchers to focus on innovation and patient care. Founded with support from Y Combinator, Mytos comprises a cross-disciplinary team of engineers and scientists dedicated to addressing real-world challenges through collaboration and rapid development. Committed to a culture of continuous improvement, Mytos values autonomy, problem-solving, and a strong passion for advancing science and technology.